Search
- Feb 1, 2021
- 1 min
Catabasis Pharmaceuticals Announces Acquisition of Quellis Biosciences Inc.
"Acquisition Includes QLS-215, a Potential Best-in-Class Monoclonal Antibody Inhibitor of Plasma Kallikrein in Preclinical Development fo...
- Jan 28, 2021
- 1 min
Pharvaris Announces Phase 1 Clinical Data of PHA121, an Oral B2 Receptor Antagonist Under...
Pharvaris Announces Phase 1 Clinical Data of PHA121, an Oral B2 Receptor Antagonist Under Developmen t for the Treatment of Hereditary...
- Jan 27, 2021
- 1 min
Notable Labs to Present Analysis of Hematologic Oncology Drug Sensitivity Data
"Notable Labs, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, today...
- Jan 27, 2021
- 1 min
Lilly, Vir Biotechnology and GSK announce first patient dosed in expanded BLAZE-4 trial evaluating..
Lilly, Vir Biotechnology and GSK announce first patient dosed in expanded BLAZE-4 trial evaluating bamlanivimab (LY-CoV555) with VIR-7831...
- Jan 22, 2021
- 1 min
aTyr Pharma to Present Poster Highlighting Research Approach for Identifying Receptor Targets for Ex
aTyr Pharma to Present Poster Highlighting Research Approach for Identifying Receptor Targets for Extracellular tRNA Synthetases "Poster...